| 151 | LEGNLegend Biotech Corp |
$1B |
-28.8% |
2025 |
| 152 | TNDMTandem Diabetes Care Inc |
$1B |
-20.2% |
2025 |
| 153 | INNVInnovAge Holding Corp. |
$989.7M |
-0.3% |
2026 |
| 154 | GHGuardant Health, Inc. |
$982M |
-42.4% |
2025 |
| 155 | MDGLMadrigal Pharmaceuticals, Inc. |
$958.4M |
-30.1% |
2025 |
| 156 | PNTGPennant Group, Inc. |
$947.7M |
3.1% |
2025 |
| 157 | IONSIonis Pharmaceuticals Inc |
$943.7M |
-40.4% |
2025 |
| 158 | USNAUsana Health Sciences Inc |
$925.3M |
1.2% |
2025 |
| 159 | TLRYTilray Brands, Inc. |
$915.5M |
-13.3% |
2026 |
| 160 | INSPInspire Medical Systems, Inc. |
$912M |
15.9% |
2025 |
| 161 | ANIPAni Pharmaceuticals Inc |
$883.4M |
8.9% |
2025 |
| 162 | BCRXBiocryst Pharmaceuticals Inc |
$874.8M |
30.2% |
2025 |
| 163 | WRBYWarby Parker Inc. |
$871.9M |
0.2% |
2025 |
| 164 | NEOGNeogen Corp |
$870.4M |
-0.9% |
2026 |
| 165 | HRMYHarmony Biosciences Holdings, Inc. |
$868.5M |
18.3% |
2025 |
| 166 | ARWRArrowhead Pharmaceuticals, Inc. |
$829.4M |
-0.2% |
2025 |
| 167 | MYGNMyriad Genetics Inc |
$824.5M |
-44.4% |
2025 |
| 168 | OFIXOrthofix Medical Inc. |
$822.3M |
-11.2% |
2025 |
| 169 | CAICaris Life Sciences, Inc. |
$812M |
-8.4% |
2025 |
| 170 | TLXTelix Pharmaceuticals Ltd |
$803.8M |
-0.9% |
2025 |
| 171 | USPHU S Physical Therapy Inc |
$781M |
5.1% |
2025 |
| 172 | COLLCollegium Pharmaceutical, Inc |
$780.6M |
8.1% |
2025 |
| 173 | ATECAlphatec Holdings, Inc. |
$764.2M |
-18.8% |
2025 |
| 174 | CORTCorcept Therapeutics Inc |
$761.4M |
13.1% |
2025 |
| 175 | IRTCiRhythm Holdings, Inc. |
$747.1M |
-6.0% |
2025 |
| 176 | EBSEmergent BioSolutions Inc. |
$742.9M |
7.1% |
2025 |
| 177 | RGENRepligen Corp |
$738.3M |
6.6% |
2025 |
| 178 | NEONeogenomics Inc |
$727.3M |
-14.9% |
2025 |
| 179 | PCRXPacira BioSciences, Inc. |
$726.4M |
1.0% |
2025 |
| 180 | AMPHAmphastar Pharmaceuticals, Inc. |
$719.9M |
13.6% |
2025 |
| 181 | SUPNSupernus Pharmaceuticals, Inc. |
$719M |
-5.4% |
2025 |
| 182 | AVNSAvanos Medical, Inc. |
$701.2M |
-10.4% |
2025 |
| 183 | KNSAKiniksa Pharmaceuticals International, plc |
$677.6M |
8.7% |
2025 |
| 184 | RAREUltragenyx Pharmaceutical Inc. |
$673M |
-85.4% |
2025 |
| 185 | CRLBFCresco Labs Inc. |
$655.8M |
-20.6% |
2025 |
| 186 | NVCRNovoCure Ltd |
$655.4M |
-20.8% |
2025 |
| 187 | AXSMAxsome Therapeutics, Inc. |
$638.5M |
-28.7% |
2025 |
| 188 | TGTXTG Therapeutics, Inc. |
$616.3M |
72.6% |
2025 |
| 189 | CDRECadre Holdings, Inc. |
$610.3M |
7.2% |
2025 |
| 190 | OPKOpko Health, Inc. |
$606.9M |
-37.2% |
2025 |
| 191 | INSMINSMED Inc |
$606.4M |
-210.5% |
2025 |
| 192 | TMDXTransMedics Group, Inc. |
$605.5M |
31.4% |
2025 |
| 193 | UFPTUfp Technologies Inc |
$602.8M |
11.3% |
2025 |
| 194 | ALVOAlvotech |
$586.3M |
4.8% |
2025 |
| 195 | BVSBioventus Inc. |
$568.1M |
4.0% |
2025 |
| 196 | RLXRLX Technology Inc. |
$566.1M |
23.3% |
2025 |
| 197 | ORGOOrganogenesis Holdings Inc. |
$564.2M |
6.6% |
2025 |
| 198 | HCMHUTCHMED (China) Ltd |
$548.5M |
83.3% |
2025 |
| 199 | ATRCAtriCure, Inc. |
$534.5M |
-2.1% |
2025 |
| 200 | MIRMMirum Pharmaceuticals, Inc. |
$521.3M |
-4.5% |
2025 |